Cargando…
Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences
BACKGROUND: In the European Union and European Economic Area only 38% of multidrug-resistant tuberculosis patients notified in 2011 completed treatment successfully at 24 months’ evaluation. Socio-economic factors and patient factors such as demographic characteristics, behaviour and attitudes are a...
Autores principales: | de Vries, Gerard, Tsolova, Svetla, Anderson, Laura F., Gebhard, Agnes C., Heldal, Einar, Hollo, Vahur, Cejudo, Laura Sánchez-Cambronero, Schmid, Daniela, Schreuder, Bert, Varleva, Tonka, van der Werf, Marieke J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395777/ https://www.ncbi.nlm.nih.gov/pubmed/28424062 http://dx.doi.org/10.1186/s12889-017-4216-9 |
Ejemplares similares
-
Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union
por: van der Werf, Marieke J., et al.
Publicado: (2017) -
Is tuberculosis crossing borders at the Eastern boundary of the European Union?
por: van der Werf, Marieke J., et al.
Publicado: (2013) -
Tools for Assessment of Country Preparedness for Public Health Emergencies: A Critical Review
por: Haeberer, Mariana, et al.
Publicado: (2021) -
Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014
por: Sotgiu, Giovanni, et al.
Publicado: (2017) -
Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles
por: van der Werf, Marieke J., et al.
Publicado: (2016)